Nudge and Motivational Interviewing Interventions to Improve Influenza Vaccine Uptake Among Healthcare Workers in China

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCenters for Disease Control and Prevention, China

About this trial

The goal of this clinical trial is to learn if nudge-based interventions and motivational interviewing work to improve influenza vaccination uptake among healthcare workers in China. A two-phase randomized controlled trial will be conducted in community hospitals across China, targeting healthcare workers as participants.

The main questions are:

Do nudge-based interventions increase vaccination rates among healthcare workers?

Does motivational interviewing increase vaccination compliance among those who remain unvaccinated after the phase 1?

In phase 1, community hospitals will be randomized as units into three arms: standard nudge group, personalized nudge group, and a control group. In phase 2, healthcare workers who remain unvaccinated after phase 1 will be individually randomized to either a motivational interviewing group or a control group.

Participants will:

Be recruited from community hospitals to participate in the study. In phase 1 (at the early stage of the flu season), community hospitals will be randomly assigned to one of three groups: standardized nudge messages, personalized nudge messages with a chatbot, or no reminders.

If still unvaccinated in phase 2 (during peak flu season), healthcare workers will be individually assigned to either motivational interviewing group or receive no extra contact.

Have their vaccination status checked at the end of each phase.

Eligibility criteria

Qualifiers

Full-time employees of community hospitals who remain employed throughout the study period.

Have not scheduled or received an influenza vaccine between August 2024 and the time of formal enrollment.

Agree to participate and provide informed consent.

Disqualifiers

Participants with medical conditions that contraindicate influenza vaccination.

Participants who refuse to participate or do not provide informed consent .

Healthcare workers from community hospitals who remain unvaccinated after Phase 1, as verified by official records, will be screened.

A selected subset of these individuals will be invited to participate in Phase 2.

Trial design

Treatments tested in this trial

  • Phase 1: standardized nudge messages
  • Phase 1: personalized nudge messages + chatbot
  • Phase 2: motivational Interviewing

Treatment groups

4,050 Participants
are divided into 5 treatment groups

Locations

This trial has no locations